Search

everythinglearnresearchcommunity

for

Search:↓

Curcumin can be effectively loaded into polystyrene nanoparticles, which are safe for human cells and more biocompatible with curcumin inside.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Juglone from walnut extracts may help repair damaged hair.

Latanoprost-loaded nanotransfersomes could help treat hair loss by promoting hair growth.

Mutations in NIPAL4 cause skin issues by disrupting lipid layers, but some improvement is seen with topical treatment.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Keratin treatment reduces astrocyte reactivity and inflammation.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Hair treatments and dehydration affect hair's lipid and protein behavior, influencing its flexibility and appearance.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Minoxidil effectively treats hair loss, with better results in women.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Finasteride and metformin both help treat PCOS, but using them together works best.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Auto-portraits help evaluate scalp hair.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

A quick and simple method was created to identify minoxidil in hair-growth products using micellar electrokinetic capillary chromatography.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.